Loading people...
Eddie Yang is a Principal on the therapeutics investment team at Deerfield Management based in New York, New York. He initially joined the prominent multi-billion-dollar healthcare investment firm in 2017 as a Fellow before advancing through the ranks to his current principal role on the investment team. Prior to his tenure at Deerfield Management, Yang gained early professional experience working at Elion. He holds a Bachelor of Arts in Entrepreneurship Management with minors in Business Analytics and Finance from The City University of New York’s Macaulay Honors College, where he graduated summa cum laude. In his current capacity, Yang focuses on evaluating and executing strategic investments across the broader healthcare, biotechnology, and life sciences sectors. His primary mandate involves directing capital toward specialized therapeutics companies to support active portfolio management and firmwide investment strategies.
Eddie Yang is an integral Analyst at Deerfield Management, a highly respected investment firm dedicated to advancing healthcare. Deerfield Management is renowned for its deep expertise in the healthcare industry, investing across various stages from early-stage biotechnology to established medical device companies and healthcare services. As an Analyst, Eddie contributes significantly to the firm's rigorous due diligence process and investment decision-making.
At Deerfield Management, Eddie's responsibilities encompass comprehensive research and analysis of potential investment targets. This involves delving into scientific literature, market trends, competitive landscapes, and regulatory environments to identify promising companies and technologies. He is instrumental in building detailed financial models, conducting valuation analyses, and preparing investment memos that inform the firm's partners and investment committees. His analytical insights help to uncover opportunities that align with Deerfield's investment thesis: supporting innovation that improves patient outcomes and reduces healthcare costs.
Eddie's investment focus areas align with Deerfield's broad mandate in healthcare and life sciences. This includes pharmaceuticals, biotechnology, medical devices, diagnostics, and healthcare information technology. He works alongside experienced investors and scientists, contributing to a collaborative environment that leverages diverse expertise to make informed investment choices. While specific notable investments made by an Analyst are typically part of a larger team effort and not individually attributed, Eddie's contributions are vital to the successful execution of Deerfield's investment strategies across its portfolio.
His career background likely reflects a strong foundation in finance, science, or a related analytical discipline, preparing him for the complex and specialized nature of healthcare investing. Professionals in his role often possess a keen ability to synthesize vast amounts of information, identify critical drivers of value, and communicate findings clearly. Eddie's dedication to understanding the intricacies of the healthcare ecosystem positions him as a valuable asset to Deerfield Management's ongoing efforts to identify and support groundbreaking advancements in medicine and patient care. His work helps ensure that capital is directed towards innovations with the potential for significant impact.
Eddie Yang is an Analyst at Deerfield Management, a leading investment firm focused on the healthcare and life sciences sectors.
As an Analyst at Deerfield Management, Eddie Yang supports investments in a wide range of healthcare and life sciences companies, including pharmaceuticals, biotechnology, medical devices, and healthcare services.
Eddie Yang works at Deerfield Management, a prominent investment firm specializing in healthcare.
